Article
Published 28 Oct 2025
Payers, Providers, And Patients – Oh My!: AI In Healthcare – Key Policy Developments And State Laws
Crowell & Moring LLP
Your search returned 6,489 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 27 Oct 2025
Xbrane Enters Into Conditional Financing Deal Related To Ranibizumab Biosimilar
Goodwin Procter LLP
Article
Published 27 Oct 2025
Our Key Takeaways From The 2025 Licensing Executives Society Annual Meeting
Ballard Spahr LLP
Article
Published 24 Oct 2025
Replay: Wearables Webinar Series, Part 1: Update On FDA Regulation On Wearables (Video)
Duane Morris LLP
Article
Published 24 Oct 2025
AI-Enabled Tech Faces Dual Hurdles In FDA Regulation, Patent Law
Marshall, Gerstein & Borun LLP
Article
Published 23 Oct 2025
Inside The FDA: Insights From Former Regulators
WIT Legal
Article
Published 22 Oct 2025
Using AI Responsibly: Balancing Innovation With Privacy
Harness IP
Article
Published 22 Oct 2025
Survey On Assessment Of Health And Environmental Hazards And Risks Of Surface-Treated Nanomaterials Will Close October 31, 2025
Bergeson & Campbell
Article
Published 22 Oct 2025
Royalty Monetizations: The "What, Why, When, Who And How" For Universities, Non-Profit Institutions And Life Sciences Companies
Foley Hoag LLP
Article
Published 21 Oct 2025
Semler Scientific AndCipria Pay $37 Million To Resolve Medical Device Fraud Allegations
Miller Shah
Article
Published 21 Oct 2025
Senate Passes 2026 NDAA Including BIOSECURE Act Amendment
Ropes & Gray LLP
Podcast
Published 21 Oct 2025
Part II: Recent Changes In Jury Dynamics And How To Prepare Your Expert Accordingly (Podcast)
Holland & Knight
Article
Published 20 Oct 2025
What To Watch: Human Cell And Tissue Product Regulation
Sheppard Mullin Richter & Hampton
Article
Published 20 Oct 2025
Assessing The Impact Of The Long-Stay Antipsychotic Measure On Access To Patient-Centered Care
Manatt, Phelps & Phillips LLP
Article
Published 17 Oct 2025
The PBM Effect: Regulatory And Market Implications For Life Sciences Companies And Healthcare Providers
Buchanan Ingersoll & Rooney PC
Article
Published 16 Oct 2025
Amgen And Biocon Settle Denosumab BPCIA Case
Goodwin Procter LLP
Article
Published 16 Oct 2025
FDA Approves Celltrion's Aflibercept Biosimilar
Goodwin Procter LLP
Article
Published 16 Oct 2025
Ohio's PBM Regulation Passed By House Of Representatives
Buchanan Ingersoll & Rooney PC
Article
Published 15 Oct 2025
The New (And Politically Improved?) BIOSECURE Act
Mintz
Article
Published 15 Oct 2025
FDCA: Fifth Circuit End-Run Suggests State Law Private Right Of Action
Foley & Lardner